There is uncertainty about access to the most commonly used method of abortion in the United States following two separate and conflicting court rulings in Texas and Washington over the legality of mifepristone.
Kacsmaryk’s decision ordering a hold on federal approval of mifepristone overruled decades of scientific approval.
